Zídek Z
Institute of Pharmacology, Academy of Sciences of Czech Republic, Prague.
Agents Actions. 1994 Oct;42(3-4):163-6. doi: 10.1007/BF01983485.
A number of compounds, in their structure similar to the immunomodulatory agent adamantylamide-L-alanyl-D-isoglutamine (AdDP), a desmuramyl analog of muramyl dipeptide (MDP), were compared with respect to their in vivo immunobiological activity. The agents were represented by adamantylamide-peptides or -amino acids differing principally in the nature of glutaminyl moieties. They were all able to induce inflammatory reaction which was prevented by anti-T-cell (TH) mAb, silica, indomethacin and dexamethasone. Responsible for this effect proved to be glutaminyl moieties (glutamine, isoglutamine, or glutamic acid), irrespective of their stereospecificity. Unlike the immunomodulatory molecule of AdDP, neither of the compounds and amino acids were able to stimulate production of antibodies in immunized animals, however.
将一些结构与免疫调节剂金刚烷酰胺-L-丙氨酰-D-异谷氨酰胺(AdDP)相似的化合物(muramyl二肽(MDP)的一种去muramyl类似物)在体内免疫生物学活性方面进行了比较。这些试剂以金刚烷酰胺-肽或 -氨基酸为代表,它们主要在谷氨酰胺部分的性质上有所不同。它们都能够诱导炎症反应,而抗T细胞(TH)单克隆抗体、二氧化硅、吲哚美辛和地塞米松可阻止这种反应。事实证明,无论其立体特异性如何,造成这种效应的是谷氨酰胺部分(谷氨酰胺、异谷氨酰胺或谷氨酸)。然而,与AdDP的免疫调节分子不同,这些化合物和氨基酸均不能刺激免疫动物产生抗体。